David James Ballance serves as Executive at PhaseBio Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, David James Ballance has executed 2 insider transactions totaling $3.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 20, 2020 involved receiving (via award) 919 shares valued at $2.8K.
David James Ballance currently holds 8,519 shares of PhaseBio Pharmaceuticals Inc (PHAS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David James Ballance has been a net buyer of PHAS stock. They have purchased $3.9K and sold $0 worth of shares.
David James Ballance's most recent insider trade was on Nov 20, 2020, when they sold 919 shares at $3.00 per share.
Get notified when new Form 4 filings are submitted
| $3.94 |
| Discretionary |